Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer [Phase 3]
Phase 3 clinical trial update for HS-20089 injection in platinum-resistant recurrent epithelial ovarian cancer; the study is currently recru…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors [Phase 2]
Phase 2 clinical trial of TJ004309 in combination with atezolizumab (TECENTRIQ) for ovarian cancer and selected solid tumors has completed e…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment [Phase 2]
Phase 2 clinical trial evaluating disitamab vedotin plus carboplatin as first-line treatment for advanced ovarian cancer; the study is curre…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating QL1706 in combination with chemotherapy and anlotinib for recurrent ovarian cancer is currently recruiti…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Phase 1 Study of LNCB74 in Advanced Solid Tumors [Phase 1]
Status update for a Phase 1 study of the investigational agent LNCB74 in patients with various advanced solid tumors, including ovarian, bre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Feasibility of CALM in Patients With Ovarian Cancer [NA]
The document reports a feasibility trial of CALM in patients with ovarian cancer and indicates that recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Nirogacestat in Ovarian Granulosa Cell Tumors [Phase 2]
Phase 2 clinical trial update for Nirogacestat in ovarian granulosa cell tumors has completed.
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study [NA]
This clinical trial aims to overcome immunosuppression and rebalance the immune response in ovarian cancer and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating Zafirlukast for marker-relapsed ovarian cancer has completed, with results posted. The study was sponsored…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics [NA]
A clinical trial update for the HOPE-Genomics intervention aimed at improving cancer patients' knowledge of genomics, with results posted on…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of MT-4561 in Patients With Various Advanced Solid Tumors [Phase 1, Phase 2]
This trial update reports that MT-4561 is being studied in multiple advanced solid tumors across Phase 1/Phase 2 and is currently recruiting…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating losartan in combination with paclitaxel for platinum-resistant ovarian cancer; recruitment has not yet sta…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer [Phase 1]
Clinical trial update indicating a Phase 1 study of PIPAC (pressurized intraperitoneal aerosol chemotherapy) to treat peritoneal carcinomato…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating paclitaxel delivered via pressurized intraperitoneal aerosol chemotherapy for platinum-resistant re…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: PONDER: Pelvic Peritonectomy in Early Stage Ovarian Tumors [NA]
The PONDER trial is studying pelvic peritonectomy for early-stage ovarian tumors with peritoneal carcinomatosis. The study status is NOT_YET…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Trop2-targeted immunoPET Imaging of Solid Tumors [Phase 2, Phase 3]
Clinical trial update for Trop2-targeted immunoPET imaging of solid tumors, currently in Phase 2/3 and recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer [Phase 1]
Phase 1 study evaluating RP-6306 in combination with carboplatin and paclitaxel for TP53-mutant recurrent ovarian and uterine cancers; the t…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance
A ClinicalTrials.gov update describes a study evaluating how dietary patterns affect prognosis for ovarian cancer patients during PARP inhib…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
This clinical trial update reports that City of Hope Medical Center's remote telemonitoring study of patient-generated physiological data an…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
Clinical trial update describing the role of oncovascular surgery in treating advanced gynecologic cancers, sponsored by the National Cancer…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery [Phase 3]
Phase 3 clinical trial evaluating whether adjusting chemotherapy dose and the SALVage weekly dose-dense regimen improves outcomes in patient…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating infusion of autologous T cells engineered to target the follicle-stimulating hormone receptor (FSHR) for r…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
This completed feasibility trial evaluated saliva-based and remote monitoring approaches for detecting active cytomegalovirus infection and …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: PROADAPT-ovary/EWOC-2 [NA]
Clinical trial PROADAPT-ovary/EWOC-2 (NCT04284969) is a study sponsored by Hospices Civils de Lyon examining treatment strategies for ovaria…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Study Looking at Biomarkers in Ovarian Cancer [NA]
A clinical trial investigating biomarkers in ovarian cancer is currently recruiting. The study is sponsored by University Health Network in …